Many people experience an itchy scalp at some point. It’s usually not a sign of a serious medical condition and can, in most cases, be successfully treated with home remedies, over-the-counter ...

While some animals like mammals have a limited ability to regenerate lost tissues, planarians can be cut roughly in half and ...

Sandalwood and Aloe Vera oil offers multiple benefits for scalp health. Sandalwood oil deeply hydrates, soothes inflammation with santalol, and balances pH levels, preventing dryness and irritation.

Zimislecel (VX-880) pivotal trial on track to complete enrollment and dosing in H1 2025; Vertex expects to submit marketing applications to global regulators in 2026 - Vertex has completed ...

That new shampoo promised incredible volume and shine, but instead delivered an itchy, irritated scalp. Sound familiar? You’re not alone. While we often focus on how hair products affect our ...

Google Cloud’s latest enhancements to Vertex AI and the Gemini model family offer businesses a comprehensive solution for building, deploying, and managing AI applications with unprecedented ...

The new skin care? Scalp care—or more specifically, a scalp “detox”…which, funnily enough, involves using more products, not less. For some of us, hair routines are as straightforward as ...

Proper summer scalp care can prevent issues like dandruff, irritation, and hair loss. Essential tips include using a hat or sunscreen for protection, washing hair 2-3 times weekly with gentle ...

The forward-looking statements contained in this Press Release are based on the expectations, estimates and projections of management of Vertex as of the date of this Press Release unless ...

Leading industry experts join the Vertex Chief Strategy Office to shape product innovation and strengthen global compliance strategies for customers KING OF PRUSSIA, Pa., April 10, 2025 (GLOBE ...

VX-264 Update Vertex has completed enrollment and dosing in Parts A and B of thePhase 1/2 VX-264 (cells + device) study and the planned analysis at Day 90 for Part B. In Part B of the study ...

Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing in Parts A and B of the Phase 1/2 VX-264 study and ...